Category: Accuray Inc.Syndicate content

Accuray's sales sink and losses narrow in Q1

November 9, 2012 by MassDevice staff

Radiotherapy devices maker Accuray reports a 18% dive in 1st-quarter sales as the company comes down from previous spikes associated with a merger.

Accuray logo

Accuray (NSDQ:ARAY) lost a little love on Wall Street after the company reported a sizable dive in sales for its 1st quarter 2013.

AtriCure welcomes new CEO | Personnel Moves

November 5, 2012 by MassDevice staff

Medical device company AtriCure names a new president & CEO after posting its 3Q earnings, which came in below analysts' estimates. 

fired/hired

 AtriCure names Michael Carrel its new CEO

Cancer: Accuray lands 510(k) clearance for next-gen CyberKnife

November 2, 2012 by MassDevice staff

The FDA grants 510(k) clearance to Accuray's CyberKnife M6 radiosurgery device for treating cancerous tumors.

Accuray

Accuray (NSDQ:ARAY) won 510(k) clearance from the FDA for the latest iteration of its CyberKnife radiosurgery device.

Chief commercial officer Kelly Londy told MassDevice.com that the Sunnyvale, Calif.-based medical device company is launching the product immediately.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Accuray details new CEO appointment | Personnel Moves

October 22, 2012 by MassDevice staff

Radiotherapy devices maker Accuray details new CEO Joshua Levine's appointment.

fired/hired

 Accuray details new CEO's position

Accuray CEO Euan Thomson quits company, replaced by Joshua Levine

October 12, 2012 by MassDevice staff

Euan Thomson abruptly resigns from Sunnyvale, Calif.-based medical device maker Accuray, will be replaced by former Mentor Corp., Immucor CEO.

Accuray logo

Medical device company Accuray (NSDQ:ARAY) said CEO Euan Thomson has left the company and will be replaced by Joshua Levine, the former CEO of Mentor Corp. and Immucor.

Cancer: Accuray's losses widen as it prepares for "major technology launch"

September 10, 2012 by MassDevice staff

Medical device maker Accuray reports that its losses jumped 170% during fiscal 2012, cautioning that Q1 results will be dramatically lower as it ramps up for a new product launch this fall.

Accuray logo

Medical device company Accuray (NSDQ:ARAY) said it's completed a "year of transition" as it looks to the release of 2 new products in October, which it says will help "change the dynamic" of the radiosurgery market.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtronic: Defibrillator market is stabilizing | Wall Street Beat

September 6, 2012 by MassDevice staff

The prolonged slump in the U.S. defibrillator market appears to have stabilized, according to medical device company Medtronic.

MassDevice.com Wall Street Beat

Medtronic (NYSE:MDT) said the slump that's hit its bread-and-butter cardiac rhythm management division where it hurts appears to have stabilized, despite the 5% sales slide during its fiscal 1st quarter.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp